STRONGBRIDGE BIOPHARMA plc SBBP Income Statement

Strongbridge biopharma plc (SBBP)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15
Revenues:
Total revenues
24,043	21,712	20,620	20,283	18,500	18,027	16,046	12,228	0	-	0	0	-	-	-	-	-	-	-	-	-
Total revenues
-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-
Cost and expenses:
Cost of sales (excluding amortization of intangible asset)
3,978	3,822	4,277	4,029	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of sales (excluding amortization of intangible assets)
-	-	-	-	-	-	-	-	0	-	0	0	-	-	-	-	-	-	-	-	-
Selling, general and administrative
47,361	49,058	53,288	60,046	63,074	63,336	57,360	46,280	41,212	36,292	29,683	24,316	18,188	14,875	0	0	0	-	-	-	-
Research and development
31,872	30,903	30,783	30,429	27,143	25,441	22,687	19,993	18,668	17,268	16,254	16,266	16,710	20,023	21,689	21,283	24,429	20,135	0	0	0
Amortization of intangible asset
5,022	5,022	5,436	6,057	6,674	7,187	6,772	6,152	5,535	5,022	0	0	0	-	-	-	-	-	-	-	-
General and administrative
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	0	0
Impairment of intangible asset
-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-
Impairment of intangible asset
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-
Total cost and expenses
88,233	88,805	93,468	100,933	101,023	99,950	90,195	95,674	88,288	80,788	77,453	0	0	-	-	0	-	-	-	-	-
Total operating expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	42,741	-	48,169	-	0	0	0
Operating loss
-64,190	-67,093	-72,848	-80,650	-82,523	-81,923	-73,698	-81,991	-77,372	-73,742	-77,933	-52,541	-51,982	-50,726	-42,741	-44,753	-48,169	-42,854	0	0	0
Other income (expenses), net:
Unrealized gain (loss) on fair value of warrants
-13,786	-11,386	-9,968	-13,897	-24,217	-16,337	-14,424	-9,246	24,990	30,218	0	0	0	-	-	-	-	-	-	-	-
Income from field services agreement
-	12,616	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Expense from field services agreement
-	6,652	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest expense
-	-	-	-	-	12,515	11,025	9,002	6,450	4,313	0	0	0	-	-	-	-	-	-	-	-
Foreign exchange loss
-	-	-	-	-	-	-	-	-	-	-42	-51	-34	-69	262	146	609	-124	0	0	0
Loss on extinguishment of debt
-	-	-	-	-	-21,549	-4,045	0	0	-	0	-	-	-	-	-	-	-	-	-	-
Other income, net
1,603	2,060	2,142	1,996	1,730	1,205	931	583	301	106	138	91	75	-1,180	-1,760	-1,808	-2,354	-1,105	0	0	0
Total other income (expenses), net
21,566	19,410	118,735	119,078	125,876	114,310	3,867	-3,192	-35,172	-37,970	-33,863	-30,963	-15,006	-631	-1,498	-1,662	-1,745	-1,229	0	0	0
Loss before income taxes
-42,624	-47,683	45,887	38,428	43,353	32,387	-69,831	-85,183	-112,544	-111,712	-111,796	-83,504	-66,988	-51,357	-44,239	-46,415	-49,914	-44,083	0	0	0
Income tax expense
1,091	1,768	1,769	0	0	-	-	0	-	1,771	-1,060	-210	-989	-2,638	-1,070	-1,198	-450	-450	0	0	0
Net income (loss)
-	-	-	-	-	-	-	-	-	-	-	-	-	-48,719	-43,169	-45,217	-49,464	-43,633	0	0	0
Net income (loss) attributable to non-controlling interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-122	-133	0	0	-	0	-	-
Net loss
-43,715	-49,451	43,584	36,816	42,140	31,851	-70,951	-85,453	-112,721	-113,483	-110,737	-83,278	-65,928	-48,597	-43,003	-45,058	-49,360	-43,580	0	0	0
Unrealized gain on marketable securities
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Comprehensive loss
0	-	-	-	0	-	-	-	-	-	-	-	-	-	0	-	-	-	0	0	0
Net loss attributable to ordinary shareholders:
Basic and diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0
Basic
-43,715	-49,451	43,584	36,816	42,140	31,851	-87,264	-96,897	0	-	0	0	-	-	-	-	-	-	-	-	-
Diluted
-55,681	-60,837	41,497	30,799	25,803	15,514	-113,413	-115,914	0	-	0	0	-	-	-	-	-	-	-	-	-
Net loss per share attributable to ordinary shareholders:
Basic (in dollars per share)
-0.23	-0.17	-0.25	-0.15	-0.34	-	-0.44	-0.06	-	-	-0.98	-0.86	-	-	-	-	-	-	-	-	-
Diluted (in dollars per share)
-0.24	-0.15	-0.31	-0.30	-0.34	-	-0.55	-0.43	-	-	-0.98	-0.86	-	-	-	-	-	-	-	-	-
Basic and diluted (in dollars per share)
-	-	-	-	-	-	-	-	-0.66	-	-	-	-0.83	-	-0.36	-0.61	-0.57	-	-0.51	-1.19	-0.52
Weighted-average shares used in computing net loss per share attributable to ordinary shareholders:
Basic and diluted
-	-	-	-	-	-	-	-	43,620	-	-	-	35,335	-	21,205	21,205	21,205	-	18,784	14,461	12,292
Basic (in shares)
54,231	54,206	54,192	54,175	54,155	-	46,978	45,829	-	-	35,716	35,335	-	-	-	-	-	-	-	-	-
Diluted (in shares)
54,444	57,055	54,540	55,781	54,155	-	50,317	50,437	-	-	35,716	35,335	-	-	-	-	-	-	-	-	-
Product
Total revenues
24,006	21,676	20,597	20,267	18,490	18,027	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Royalty
Total revenues
37	36	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-